JP Morgan Private Wealth Advisors’s CONMED CNMD Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.26M	Sell	12,496 -478	-4%	-$54.9K	﹤0.01%	896
2023 Q2	$1.76M	Sell	12,974 -5,860	-31%	-$715K	0.01%	608
2023 Q1	$1.96M	Buy	18,834 +1,964	+12%	+$190K	﹤0.01%	885
2022 Q4	$1.5M	Sell	16,870 -542	-3%	-$45K	﹤0.01%	955
2022 Q3	$1.4M	Buy	17,412 +2,744	+19%	+$259K	﹤0.01%	991
2022 Q2	$1.41M	Buy	14,668 +774	+6%	+$92.9K	﹤0.01%	973
2022 Q1	$2.06M	Buy	13,894 +4,998	+56%	+$698K	﹤0.01%	887
2021 Q4	$1.26M	Buy	8,896 +1,667	+23%	+$236K	﹤0.01%	1121
2021 Q3	$946K	Buy	7,229 +1,681	+30%	+$220K	﹤0.01%	1239
2021 Q2	$762K	Buy	+5,548	New	+$760K	﹤0.01%	1322

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Private Wealth Advisors's CNMD Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its CONMED (CNMD) stake by 3.7% in Q3 2023, selling an estimated $54.9K and leaving 12,496 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #896.

JP Morgan Private Wealth Advisors first reported a position in CNMD in Q2 2021 and has held it in 10 quarters since. The position peaked at $2.06M in Q1 2022. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

JP Morgan Private Wealth Advisors held 12,496 shares of CONMED worth $1.26M as of Q3 2023.
JP Morgan Private Wealth Advisors sold 478 CONMED shares in Q3 2023, an estimated $54.9K.
CONMED made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #896 holding.
JP Morgan Private Wealth Advisors first reported a position in CONMED in Q2 2021 and has held it in 10 quarters since.
JP Morgan Private Wealth Advisors's CONMED position peaked at $2.06M in Q1 2022.
275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.